The reaction of N -(2-pyridinyl)piperazines with CO (15 atm) and ethylene in the presence of a catalytic amount of Rh 4 (CO) 12 in toluene at 160 °C resulted in a novel carbonylation reaction, which involves dehydrogenation and carbonylation at a C−H bond. The carbonylation takes place regioselectively at a C−H bond α to the nitrogen atom substituted by a pyridine. The presence of an additional nitrogen functionality at the 4-position of the piperazine ring is also essential for the reaction to proceed. The electronic nature of subsituents, both on the 4-nitrogen and in the pyridine ring, affects significantly the reactivity of the substrates. The substitution of an electron-donating group on the 4-nitrogen causes an increase in reactivity, as does the substitution of an electron-withdrawing group in the pyridine ring. It is found that the reaction involves two discrete reactions: (i) dehydrogenation of the piperazine ring and (ii) carbonylation at a C−H bond in the resulting olefin. The reaction proceeds via two cleavages of the C−H bond, first at the sp 3 C−H bond and then at the sp 2 C−H bond. The reaction stops at the dehydrogenation step by replacement of the pyridinyl group with a phenyl group. Rhodium complexes are the only active catalysts for the present reaction.
No takes yet. Share an insight, caveat, or question.
Ishii et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: